-
Provisions for Toothpaste Regulation
2024-06-05
Promulgated by SAMR Decree No. 71, issued on March 16, 2023 and shall go into effect as of December 1, 2023
-
NMPA Announcement on Provisions for Cosmetic Inspections (No. 52, 2024)
2024-04-29
To strengthen the supervision and administration and regulate cosmetic inspections, according to the Regulations on Supervision and Administration of Cosmetics, the Provisions for Registration and Notification of Cosmetics and the Provisions for Supervision and Administration of Cosmetic Manufacturing and Distribution, the NMPA formulated the Provisions for Cosmetic Inspections, which is hereby issued and will come into force from November 1, 2024.
-
NMPA Announcement on the Matters Related to Optimizing the Application for Marketing and Registration of Drugs Manufactured Overseas and Marketed in China to be Transferred to Domestic Manufacturing
2024-04-23
To further optimize the foreign investment environment, promote the high-quality development in the pharmaceutical industry, improve the drug accessibility, and meet our people’s need, in accordance with the requirements of the Opinions on Further Optimizing the Foreign Investment Environment and Increasing the Efforts to Attract Foreign Investments (GF [2023] No. 11) issued by State Council, and the NMPA Announcement on Provisions for Post-approval Changes of Drugs (Interim) (No. 8, 2021), regarding the optimization of the application procedures for marketing and registration of drugs manufactured overseas and marketed in China to be transferred to domestic manufacturing, the relevant matters are hereby announced as follows.
-
NMPA Announcement on Several Measures to Optimize the Management of Cosmetic Safety Assessment (No. 50, 2024)
2024-04-22
To further optimize the management of cosmetic safety assessment and orderly promote the implementation of the cosmetic safety assessment system, according to the Regulations on Supervision and Administration of Cosmetics, the Provisions for Registration and Notification of Cosmetics and the Technical Guidance for the Safety Evaluation of Cosmetics (2021 Edition) (hereinafter referred to as the Guidance) and other relevant regulatory requirements, the NMPA formulated Several Measures to Optimize the Management of Cosmetic Safety Assessment, which are hereby issued and will come into force from May 1, 2024.
-
Announcement on Issuing the Guideline for the Collection and Reporting of Adverse Reactions to Cosmetics by Cosmetic Registrant and Filing Entity (Interim)
2024-04-19
To regulate and guide cosmetic registrants and filing entities to carry out the collection and reporting of adverse reactions to cosmetics, according to the Regulations on Supervision and Administration of Cosmetics, the Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics, the Provisions for the Administration of Adverse Reaction Monitoring of Cosmetics and other relevant provisions, in accordance with the requirements of the National Medical Products Administration, the National Center for ADR Monitoring organized to formulate the Guideline for the Collection and Reporting of Adverse Reactions to Cosmetics by Cosmetic Registrant and Filing Entity (Interim), which is hereby issued.
-
NMPA Announcement on Further Strengthening the Supervision and Administration of Entrusted Manufacturing by Registrants of Medical Devices (No.38, 2024)
2024-04-03
Pursuant to the implementation of the Regulations for the Supervision and Administration of Medical Devices, and with the objective of fully enforcing the primary responsibility for quality and safety on the part of the registrant of medical devices (hereinafter referred to as “Registrant”), this announcement aims to further strengthen the supervision and administration of entrusted manufacturing by registrants of medical devices, and enable effective prevention and control of quality and safety risks associated with medical devices.